Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Insulet Corporation (NASDAQ:PODD). In a filing disclosed on September 10th, the Representative disclosed that they had bought between $1,001 and $15,000 in Insulet stock on August 18th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Sold $1,001 – $15,000 in shares of DoorDash (NASDAQ:DASH) on 8/28/2026.
- Purchased $15,001 – $50,000 in shares of Quanta Services (NYSE:PWR) on 8/27/2026.
- Purchased $15,001 – $50,000 in shares of Eaton (NYSE:ETN) on 8/27/2026.
- Sold $15,001 – $50,000 in shares of NIKE (NYSE:NKE) on 8/27/2026.
- Sold $1,001 – $15,000 in shares of Phreesia (NYSE:PHR) on 8/26/2026.
- Purchased $1,001 – $15,000 in shares of Wheaton Precious Metals (NYSE:WPM) on 8/26/2026.
- Purchased $1,001 – $15,000 in shares of Walmart (NASDAQ:WMT) on 8/26/2026.
- Purchased $1,001 – $15,000 in shares of The Goldman Sachs Group (NYSE:GS) on 8/26/2026.
- Sold $15,001 – $50,000 in shares of Lamar Advertising (NASDAQ:LAMR) on 8/25/2026.
- Sold $1,001 – $15,000 in shares of Phreesia (NYSE:PHR) on 8/25/2026.
Insulet Stock Performance
Shares of PODD stock opened at $131.96 on Friday. Insulet Corporation has a 12-month low of $126.40 and a 12-month high of $354.88. The business’s fifty day simple moving average is $152.36 and its 200-day simple moving average is $173.92. The company has a current ratio of 2.48, a quick ratio of 1.83 and a debt-to-equity ratio of 0.65. The company has a market cap of $9.15 billion, a PE ratio of 24.67, a PEG ratio of 1.06 and a beta of 1.08.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on the company. Bank of America cut their price objective on shares of Insulet from $288.00 to $208.00 and set a “buy” rating on the stock in a report on Monday, May 18th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $152.00 target price (down from $275.00) on shares of Insulet in a research report on Thursday, August 6th. Evercore set a $180.00 price target on Insulet in a research note on Monday, July 6th. Raymond James Financial reaffirmed an “outperform” rating and set a $180.00 target price on shares of Insulet in a report on Thursday, August 6th. Finally, BTIG Research cut shares of Insulet from a “buy” rating to a “neutral” rating in a research note on Thursday, August 6th. Fourteen analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, Insulet currently has an average rating of “Hold” and a consensus price target of $195.40.
Get Our Latest Stock Analysis on Insulet
Institutional Investors Weigh In On Insulet
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Larson Financial Group LLC lifted its stake in shares of Insulet by 114.6% in the 4th quarter. Larson Financial Group LLC now owns 88 shares of the medical instruments supplier’s stock valued at $25,000 after purchasing an additional 47 shares during the last quarter. University of Texas Texas AM Investment Management Co. acquired a new position in Insulet in the fourth quarter valued at about $26,000. Elyxium Wealth LLC purchased a new position in Insulet during the fourth quarter worth about $28,000. DV Equities LLC purchased a new position in Insulet during the fourth quarter worth about $28,000. Finally, MV Capital Management Inc. acquired a new stake in shares of Insulet during the fourth quarter valued at about $29,000.
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
Insulet Company Profile
Insulet Corporation is a medical device company that develops, manufactures and sells wearable insulin delivery systems for people with insulin-dependent diabetes. Its products are designed to provide an alternative to traditional insulin injections and conventional tubed insulin pumps.
The company’s principal product platform is Omnipod, a tubeless, wearable insulin pump system. Omnipod products include the disposable, wearable Pod and related management and smartphone-based technologies.
Featured Stories
- Five stocks we like better than Insulet
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Insulet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Insulet and related companies with MarketBeat.com's FREE daily email newsletter.
